Table 1 Clinical characteristics of the APOLLO-2 high grade serous ovarian cancer patient cohort
Clinical characteristic | Case (%) |
|---|---|
Age at diagnosis | |
<50 years old | 5 (7) |
50–59 years old | 23 (33) |
60–69 years old | 27 (39) |
70–80+years old | 15 (21) |
Race and ethnicity | |
Non-Hispanic White | 62 (89) |
Non-Hispanic Black | 4 (5.5) |
Hispanic, Asian/Pacific Islander, Mixed | 4 (5.5) |
Stage at diagnosis | |
III | 52 (74) |
IV | 18 (26) |
Topographic site | |
Ovarian | 36 (51) |
Tubal | 15 (21) |
Tubo-Ovarian | 13 (19) |
Peritoneal | 6 (9) |
Disease distribution | |
High | 49 (70) |
Moderate | 17 (24) |
Low | 4 (6) |
Residual disease | |
R0 (none or microscopic) | 27 (39) |
R1 (macroscopic >1 cm) | 43 (61) |
Progression-free survival | |
No Recurrence or Progression | 10 (14) |
Recurrence or Progression | 60 (86) |
Vital status | |
Alive | 26 (37) |
Dead | 44 (63) |
